PSC
SVNT

Prentiss Smith & Co’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Prentiss Smith & Co’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$1K – 370
2015
Q3 		$1K Hold
100
– – ﹤0.01% 331
2015
Q2 		$1K Hold
100
– – ﹤0.01% 312
2015
Q1 		$0 Hold
100
– – ﹤0.01% 338
2014
Q4 		$1K Hold
100
– – ﹤0.01% 317
2014
Q3 		$0 Hold
100
– – ﹤0.01% 255
2014
Q2 		$0 Hold
100
– – ﹤0.01% 258
2014
Q1 		$0 Hold
100
– – ﹤0.01% 269
2013
Q4 		$1K Hold
100
– – ﹤0.01% 247
2013
Q3 		$1K Hold
100
– – ﹤0.01% 240
2013
Q2 		$1K Buy
+100
New +$70 ﹤0.01% 259

Prentiss Smith & Co's SVNT Position: Q4 2015 in Review

Prentiss Smith & Co sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2015, closing a stake of 100 shares — an estimated $1K sold.

Prentiss Smith & Co first reported a position in SVNT in Q2 2013 and held it in 10 quarters. The position peaked at $1K in Q3 2015. 2 funds tracked by Wall St. Rank hold SVNT as of Q4 2015.

  • Prentiss Smith & Co reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
  • Prentiss Smith & Co sold 100 SAVIENT PHARMACEUTICALS INC shares in Q4 2015, an estimated $1K.
  • Prentiss Smith & Co first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 10 quarters.
  • Prentiss Smith & Co's SAVIENT PHARMACEUTICALS INC position peaked at $1K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2015.

Based on Prentiss Smith & Co's 13F filing for Q4 2015, filed 21 Jan 2016.